Literature DB >> 34021475

Human TAF-Iα promotes oncogenic transformation via enhancement of cell proliferation and suppression of apoptosis.

Valentina V Nenasheva1, Irina V Makarova2, Ekaterina A Stepanenko2, Stanislav A Antonov2, Ekaterina V Novosadova2, Anastasia R Narsullaeva2, Larisa V Kozikova3, Ekaterina A Polteva3, Lyudmila A Sleptsova4, Natalya A Shcherbatova2, Nella V Khaidarova2, Lyudmila E Andreeva2, Vyacheslav Z Tarantul2.   

Abstract

Template activating factor-I (TAF-I) is a multifunctional protein involved in various biological processes including the inhibition of histone acetylation, DNA replication, cell cycle regulation, and oncogenesis. Two main TAF-I isoforms with different N-termini, TAF-Iα and TAF-Iβ (SET), are expressed in cells. There are numerous data about functional properties of TAF-Iβ, whereas the effects of TAF-Iα remain largely unexplored. Here, we employed focus formation and cell proliferation assays, TUNEL staining, cytological analysis, and RT-qPCR to compare the effects of human TAF-Iα and TAF-Iβ genes, transiently expressed in Rat2 cells and in Misgurnus fossilis loaches. We found that both TAF-I isoforms possessed equal oncogenic potential in these systems. Furthermore, an overexpression of human TAF-Iα and TAF-Iβ in Rat2 cells promoted their proliferation. Accordingly, the mitotic index was increased in the transgenic loaches expressing human TAF-Iα or TAF-Iβ. TUNEL assay as well as downregulation of p53 gene and upregulation of bcl-2 gene in these transgenic loaches demonstrated that both isoforms suppressed apoptosis. Thus, TAF-Iα isoform exerts the same oncogenic potential as TAF-Iβ, likely by suppressing the apoptosis and promoting cell proliferation.

Entities:  

Keywords:  Apoptosis; Misgurnus fossilis; Oncogenesis; Rat2 cells; TAF-Iα; TAF-Iβ

Mesh:

Substances:

Year:  2021        PMID: 34021475     DOI: 10.1007/s11626-021-00572-8

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  32 in total

1.  [Loach spermatozoa transfer foreign DNA, which expression is discovered in the early development stages].

Authors:  L E Andreeva; L A Sleptsova; A P Grigorenko; A V Gavriushkin; A V Kuznetsov
Journal:  Genetika       Date:  2003-06

2.  [The plasmid pEJ6.6 carrying the activated c-Ha-ras-1 oncogene increases the mutation frequency in Chinese hamster cells].

Authors:  E M Baron; I V Bobrysheva; N B Varshaver
Journal:  Genetika       Date:  1992-06

3.  Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding.

Authors:  Xingming Deng; Fengqin Gao; W Stratford May
Journal:  Blood       Date:  2008-10-09       Impact factor: 22.113

4.  Sp1-mediated transcription regulation of TAF-Ialpha gene encoding a histone chaperone.

Authors:  Masamitsu N Asaka; Kensaku Murano; Kyosuke Nagata
Journal:  Biochem Biophys Res Commun       Date:  2008-09-20       Impact factor: 3.575

5.  Template Activating Factor-I α Regulates Retroviral Silencing during Reprogramming.

Authors:  Phuong Linh Bui; Ken Nishimura; Gonzalo Seminario Mondejar; Arun Kumar; Shiho Aizawa; Kensaku Murano; Kyosuke Nagata; Yohei Hayashi; Aya Fukuda; Yasuko Onuma; Yuzuru Ito; Mahito Nakanishi; Koji Hisatake
Journal:  Cell Rep       Date:  2019-11-12       Impact factor: 9.423

6.  Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia.

Authors:  Ion Cristóbal; Laura Garcia-Orti; Cristina Cirauqui; Xabier Cortes-Lavaud; María A García-Sánchez; María J Calasanz; María D Odero
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

7.  DNA amplification and neoplastic transformation mediated by a herpes simplex DNA fragment containing cell-related sequences.

Authors:  R J Jariwalla; B Tanczos; C Jones; J Ortiz; S Salimi-Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  SET alpha and SET beta mRNA isoforms in chronic lymphocytic leukaemia.

Authors:  Danielle M Brander; Daphne R Friedman; Alicia D Volkheimer; Dale J Christensen; Laura Z Rassenti; Thomas J Kipps; Eross Guadalupe; Youwei Chen; Dadong Zhang; Xi Wang; Carter Davis; Kouros Owzar; J Brice Weinberg
Journal:  Br J Haematol       Date:  2018-11-15       Impact factor: 6.998

Review 9.  Oncogenic Role of SET/I2PP2A for Gynecologic Cancers.

Authors:  Shi-Wen Jiang; Siliang Xu; Haibin Chen; Jiayin Liu; Ping Duan
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

10.  Silencing of IFN-stimulated gene transcription is regulated by histone H1 and its chaperone TAF-I.

Authors:  Shinichi Kadota; Kyosuke Nagata
Journal:  Nucleic Acids Res       Date:  2014-05-30       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.